DB
CRL icon

Danske Bank’s Charles River Laboratories CRL Stock Holding History

Danske Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.7K Hold
100
– – ﹤0.01% 727
2026
Q1 		$17.3K Sell
100
-50,916
-100% -$9.44M ﹤0.01% 743
2025
Q4 		$10.2M Buy
51,016
+25,005
+96% +$4.54M 0.02% 445
2025
Q3 		$4.07M Sell
26,011
-10,676
-29% -$1.7M 0.01% 553
2025
Q2 		$5.57M Buy
36,687
+36,187
+7,237% +$4.83M 0.01% 526
2025
Q1 		$75.3K Sell
500
-15,255
-97% -$2.56M ﹤0.01% 953
2024
Q4 		$2.91M Buy
15,755
+500
+3% +$96.3K 0.01% 599
2024
Q3 		$3M Buy
15,255
+300
+2% +$62.3K 0.01% 608
2024
Q2 		$3.09M Sell
14,955
-7,270
-33% -$1.65M 0.01% 597
2024
Q1 		$6.02M Buy
+22,225
New +$5.31M 0.02% 537

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Danske Bank's CRL Position: Q2 2026 in Review

Danske Bank held its Charles River Laboratories (CRL) position steady in Q2 2026 at 100 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #727.

Danske Bank first reported a position in CRL in Q1 2024 and has held it in 10 quarters since. The position peaked at $10.2M in Q4 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Danske Bank held 100 shares of Charles River Laboratories worth $22.7K as of Q2 2026.
  • Danske Bank left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #727 holding.
  • Danske Bank first reported a position in Charles River Laboratories in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Charles River Laboratories position peaked at $10.2M in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.